Synergistic cardioprotection by liraglutide and deferoxamine against doxorubicin-induced cardiotoxicity via modulation of ACSL-4/Nrf-2/GPX-4 signaling.
Medicine
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.